Trevena Drug Patent Portfolio
Trevena owns 1 orange book drug protected by 5 US patents Given below is the list of Trevena's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11077098 | Opioid receptor ligands and methods of using and making same | 23 Mar, 2032 | Active |
| US11931350 | Opioid receptor ligands and methods of using and making same | 23 Mar, 2032 | Active |
| US8835488 | Opioid receptor ligands and methods of using and making same | 23 Mar, 2032 | Active |
| US9309234 | Opioid receptor ligands and methods of using and making same | 23 Mar, 2032 | Active |
| US9642842 | Opioid receptor ligands and methods of using and making same | 23 Mar, 2032 | Active |
Latest Legal Activities on Trevena's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Trevena.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent Term Extension Certificate | 11 Aug, 2025 | US9309234 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 15 Apr, 2025 | US11077098 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 15 Apr, 2025 | US9642842 |
| 7.5 yr surcharge - late pmt w/in 6 mo, Small Entity | 15 Apr, 2025 | US9642842 |
| Surcharge for late Payment, Small Entity | 15 Apr, 2025 | US11077098 |
| Withdrawal of Application for PTE | 25 Mar, 2025 | US8835488 |
| Withdrawal of Application for PTE | 25 Mar, 2025 | US9642842 |
| Maintenance Fee Reminder Mailed | 24 Mar, 2025 | US11077098 |
| Election in Response to Notice of Final Determination | 21 Mar, 2025 | US9309234 |
| Notice of Final Determination -Election Required | 04 Mar, 2025 | US9309234 |
| Notice of Final Determination -Election Required | 04 Mar, 2025 | US9642842 |
| Notice of Final Determination -Election Required | 04 Mar, 2025 | US8835488 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 13 Feb, 2025 | US9642842 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 13 Feb, 2025 | US9309234 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 13 Feb, 2025 | US8835488 |
Trevena Drug Patents' Oppositions Filed in EPO
Trevena drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Feb 28, 2018, by Generics (Uk) Ltd. This opposition was filed on patent number EP12760456A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP12760456A | Feb, 2018 | Generics (UK) Ltd | Opposition rejected |
Trevena's Family Patents
Trevena Drug List
Given below is the complete list of Trevena's drugs and the patents protecting them.
1. Olinvyk
Olinvyk is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11077098 | Opioid receptor ligands and methods of using and making same |
23 Mar, 2032
(6 years from now)
| Active |
| US11931350 | Opioid receptor ligands and methods of using and making same |
23 Mar, 2032
(6 years from now)
| Active |
| US8835488 | Opioid receptor ligands and methods of using and making same |
23 Mar, 2032
(6 years from now)
| Active |
| US9309234 | Opioid receptor ligands and methods of using and making same |
23 Mar, 2032
(6 years from now)
| Active |
| US9642842 | Opioid receptor ligands and methods of using and making same |
23 Mar, 2032
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Olinvyk's drug page